Xenon Pharmaceuticals Inc.
SEC Filing List
XENE CIK: 0001582313
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | SCHULTE ROTH & ZABEL LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Gannon Steven | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/13/2026 | |
| 8-K | Current report filing | Xenon Pharmaceuticals Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Xenon Pharmaceuticals Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| ARS | Annual report to security holders | Xenon Pharmaceuticals Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/22/2026 | |
| DEF 14A | Definitive proxy statements | Xenon Pharmaceuticals Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/22/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Xenon Pharmaceuticals Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/22/2026 | |
| 8-K | Current report filing | Xenon Pharmaceuticals Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/13/2026 | |
| No record found. | |||||
| Load More | |||||
